Axcelis Technologies's biggest risks in the FY2024 10-K
- International sales, particularly in Asia and China, drive most revenue, exposing Axcelis to significant U.S. export control risks.
The risks most specific to Axcelis Technologies
- Risks Related to Our Business and Industry
Axcelis is subject to the risks of operating internationally: we derive a substantial portion of our revenue from outside the United States, especially from Asia
International sales, especially in Asia, accounted for 85.8% of total revenue in 2024.
- Risks Related to Our Business and Industry
that sales to Chinese customers (both global and domestic Chinese chip manufacturers) will continue to represent a significant portion of our total sales, creating both risk and opportunity
U.S. export controls require licenses for shipments to Chinese customers like SMIC, creating sales uncertainty.
- Risks Related to Our Business and Industry
We are dependent on sales to a limited number of large customers; the loss of a significant customer or any reduction in orders from them could materially affect our sales
Top ten customers accounted for 45.9% of net sales in 2024 without long-term purchase agreements.
- Risks Related to Our Business and Industry
Our financial results may fluctuate significantly
Ion implant systems range from $2.6 million to $12.0 million, making quarterly results volatile.
- Risks Related to Our Business and Industry
If operations were to be disrupted at Axcelis’ manufacturing facilities, it would have a negative impact on our business
The primary manufacturing facility is located in Massachusetts, making operations vulnerable to localized disruptions.
- Risks Related to Our Business and Industry
We are also subject to laws and regulations in various jurisdictions that determine how much profit has been
The Inflation Reduction Act imposes a 15% book minimum tax on corporations exceeding $1 billion in income.
All 24 risk factors
Headings as the filing states them, in filing order.
Risks Related to Our Business and Industry
- 01If semiconductor chip manufacturers do not make sufficient capital expenditures, our sales and profitability will be harmed
- 02If we fail to develop and introduce reliable new or enhanced products and services that meet the needs of semiconductor chip manufacturers, our results will suffer
- 03Axcelis is subject to the risks of operating internationally: we derive a substantial portion of our revenue from outside the United States, especially from Asia
- 04that sales to Chinese customers (both global and domestic Chinese chip manufacturers) will continue to represent a significant portion of our total sales, creating both risk and opportunity
- 05Our dependence upon suppliers for many components and sub-assemblies could result in increased costs or delays in the manufacture and sale of our products
- 06suppliers increase the cost of components or sub-assemblies, we may not have alternative sources of supply and may not be able to raise the price of our products to cover all or part of the increased cost of components, negatively impacting our gross margin
- 07A significant portion of our revenue depends on customers electing to buy aftermarket products and services from Axcelis
- 08If we fail to compete successfully in the highly competitive semiconductor capital equipment industry, our sales and profitability will decline
- 09We are dependent on sales to a limited number of large customers; the loss of a significant customer or any reduction in orders from them could materially affect our sales
- 10Our international operations involve currency risk
- 11We may not be able to maintain and expand our business if we are not able to hire, retain and integrate qualified personnel
- 12Our financial results may fluctuate significantly
- 13Our financial results may fall short of anticipated levels because forecasting revenue and profitability is complex and may be inaccurate
- 14customer acceptances or in revenue from new orders, including aftermarket revenue, could materially affect our financial results
- 15The semiconductor equipment industry is cyclical and we expect that demand for our products will increase and decrease, making it difficult to manage the business and potentially causing harm to our sales and profitability
- 16Axcelis is exposed to risks related to cybersecurity threats and incidents
- 17Axcelis is subject to risks associated with compliance with environmental, health and safety regulations
- 18Our financial condition and results of operations could be adversely affected by global pandemics
- 19Our proprietary technology may be vulnerable to efforts by competitors to challenge or design around, potentially reducing our market share
- 20We (or customers that we indemnify) might face intellectual property infringement claims or patent disputes that may be costly to resolve and, if resolved against us, could be very costly to us and prevent us from making and selling our systems
- 21If operations were to be disrupted at Axcelis’ manufacturing facilities, it would have a negative impact on our business
- 22If we do not have access to capital on favorable terms, on the timeline we anticipate, or at all, our financial condition and results of operations could be materially adversely affected
- 23The market price of our common stock may be volatile, which could result in substantial losses for investors
- 24We are also subject to laws and regulations in various jurisdictions that determine how much profit has been
Other Axcelis Technologies 10-Ks
- FY2025 10-K risk factors37 risks16 new3 dropped6 reworded
Axcelis faces significant new merger risks regarding Veeco, alongside evolving tariff regulations and fluctuating customer concentration metrics.
Filed Feb 26, 2026
About this page
The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.